185 related articles for article (PubMed ID: 35606079)
21. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
[TBL] [Abstract][Full Text] [Related]
22. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
Armstrong VW
Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
Scanu AM
Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
[TBL] [Abstract][Full Text] [Related]
25. Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding: An in vitro study using plasma from children with idiopathic nephrotic syndrome.
Soulat T; Loyau S; Baudouin V; Maisonneuve L; Hurtaud-Roux MF; Schlegel N; Loirat C; Anglés-Cano E
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):575-84. PubMed ID: 10669658
[TBL] [Abstract][Full Text] [Related]
26. [Molecular patho-biochemistry and genetic diagnosis for plasminogen-apolipoprotein (a) gene family related to atherosclerosis and thrombosis].
Ichinose A
Rinsho Byori; 1998 Dec; 46(12):1210-8. PubMed ID: 9916506
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein (a): implication in atherothrombosis.
Chapman MJ; Huby T; Nigon F; Thillet J
Atherosclerosis; 1994 Oct; 110 Suppl():S69-75. PubMed ID: 7857388
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein (a) in the regulation of fibrinolysis.
Edelberg JM; Pizzo SV
J Atheroscler Thromb; 1995; 2 Suppl 1():S5-7. PubMed ID: 9225222
[TBL] [Abstract][Full Text] [Related]
30. Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases.
de la Peña-Díaz A; Cardoso-Saldaña G; Zamora-González J; Barinagarrementeria F; Izaguirre R; Loyau S; Anglés-Cano E
Eur J Clin Invest; 2003 Feb; 33(2):99-105. PubMed ID: 12588282
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments.
Rouy D; Koschinsky ML; Fleury V; Chapman J; Anglés-Cano E
Biochemistry; 1992 Jul; 31(27):6333-9. PubMed ID: 1627572
[TBL] [Abstract][Full Text] [Related]
32. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein Lp(a) and atherothrombotic disease.
de la Peña-Díaz A; Izaguirre-Avila R; Anglés-Cano E
Arch Med Res; 2000; 31(4):353-9. PubMed ID: 11068075
[TBL] [Abstract][Full Text] [Related]
34. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
35. Does Lp(a) lipoprotein inhibit the fibrinolytic system?
Halvorsen S; Skjønsberg OH; Berg K; Ruyter R; Godal HC
Thromb Res; 1992 Nov; 68(3):223-32. PubMed ID: 1471070
[TBL] [Abstract][Full Text] [Related]
36. Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. An in vitro study.
Rouy D; Laplaud PM; Saboureau M; Anglés-Cano E
Arterioscler Thromb; 1992 Feb; 12(2):146-54. PubMed ID: 1531929
[TBL] [Abstract][Full Text] [Related]
37. Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein.
Koschinsky ML
Curr Atheroscler Rep; 2005 Sep; 7(5):389-95. PubMed ID: 16105483
[TBL] [Abstract][Full Text] [Related]
38. A potential basis for the thrombotic risks associated with lipoprotein(a).
Miles LA; Fless GM; Levin EG; Scanu AM; Plow EF
Nature; 1989 May; 339(6222):301-3. PubMed ID: 2542796
[TBL] [Abstract][Full Text] [Related]
39. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?
Smith EB; Crosbie L
Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924
[TBL] [Abstract][Full Text] [Related]
40. Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis.
Boffa MB; Marar TT; Yeang C; Viney NJ; Xia S; Witztum JL; Koschinsky ML; Tsimikas S
J Lipid Res; 2019 Dec; 60(12):2082-2089. PubMed ID: 31551368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
